$4550
$3640
The 3D printed drugs marketwas valued at US$ 28.52million in 2019 and is expected to grow at a CAGR of 9.1% from 2020to 2027 to reach US$57.03million by 2027.
3D printed drugs are medications, which are designed by 3D printing technique to customize for the individuals in a safer and effective way. These drugs have unitary porous structures that readily disperse in the mouth, because of which these high-dose medicines need not to be swallowed intact. The main idea behind 3D printing drugs is to design and develop medicines that are suited to an individual's needs.The global 3D printed drugs market is driven by factors such asincreasing adoption of personalized drugs. Additionally, growing research and development activities,coupled with increasing prevalence of dysphagia,is also anticipated to drive the 3D market growth during the forecast period. However, the usage of 3D printing to develop illegal drugs restrains the growth of the market. The developing healthcare infrastructure and increasing awareness regarding 3D printing in pharmaceuticals generate lucrative opportunities for the growth of the market.
Lucrative Regional 3D Printed Drugs Markets
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Increasing Adoption of Personalized Drugs
Personalized medicine is a growing area of treatment that relies on specific drug delivery and dosing. As per a study published by PMC, personalized medicines accounted for only 5% of the new FDA approved molecular entities in 2005; whereas, in 2016, they accounted for more than 25%. Additionally, 42% of all compounds and 73% of oncology compounds in the pipeline have the potential to be personalized medicines. Moreover, biopharmaceutical companies nearly doubled their R&D investment in personalized drugs over the past five years, and expect to increase their investment by 33% in the next five years. Biopharmaceutical researchers also predict a 69% increase in the number of personalized medicines in development over the coming five years.
3D printing offers the possibility of creating a personalized medicine system through automated control over drug dose and is suitable for both low and high drug concentrations. These advantages allow drug companies to not only boost efficacy and adherence, but also contribute to their brand longevity by expanding and capturing market share with other dosage forms. Through this breakthrough method of manufacturing and its fast-melt capabilities, there is an ability to overcome several obstacles, thereby contributing to better patient outcomes in the solid dose market. For instance, FabRx Ltd. completed the world’s first in-human clinical study using their proprietary Printlets technology, which relies on personalized 3D printed dosage forms to treat children with a rare metabolic disease. Additionally, the same company launched the first pharmaceutical 3D printer, M3DIMAKER, for the manufacture of personalized medicines in April 2020. Hence, there is a need for new manufacturing systems to prepare personalized medicines, and this potential application of 3D printing for rare diseases is countless. It could help make the medication safer and more attractive to children, thereby propelling the growth of the 3D printed drugs market.
Dosage Form-BasedInsights
Based on dosage form, the 3D printed drugs market is segmented into tablets, capsules, multi drug implants, nanoparticles, solutions, and other dosage forms. In 2019, thetabletssegment held the largest share of the market, and it is further expected to register the highest CAGR in the market during the forecast period. At present, 3D printed drugs are available only in the form of tablets in the market. However, the other dosage forms are likely to be commercialized in the coming years.
3D Printed Drugs Market, by Dosage Form– 2019 and 2027
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Technology-BasedInsights
Based on technology, the 3D printed drugs market is segmented into inkjet printing, direct write, zip dose, thermal inkjet printing, fused deposition modeling, powder bed printing, stereolithography (SLA), and semi solid extrusion (SSE). The zip dose technology segmentheld the largest share of the market; moreover, it is expected to register the highest CAGR during the forecast period.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
3D Printed Drugs Market: Strategic Insights
Market Size Value in US$ 28.52 Million in 2019 Market Size Value by US$ 57.03Million by 2027 Growth rate CAGR of 9.1% from 2020-2027 Forecast Period 2020-2027 Base Year 2020
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
3D Printed Drugs Market: Strategic Insights
| Market Size Value in | US$ 28.52 Million in 2019 |
| Market Size Value by | US$ 57.03Million by 2027 |
| Growth rate | CAGR of 9.1% from 2020-2027 |
| Forecast Period | 2020-2027 |
| Base Year | 2020 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Product launches and FDA approvalsis a commonly adopted strategy by companies to expand their footprint worldwide and meet the growing demand as the strategy allows them to expand their product portfolios.
The 3D printed drugs marketplayers also adopt the strategy ofcollaborations, which enables them enlarge their global customer base,alongside helping them maintain their brand names.
3D Printed Drugs Market – By Dosage Forms
- Tablets
- Capsules
- Multi Drug Implants
- Nanoparticles
- Solutions
- Others
3D Printed Drugs Market – By Technology
- Inkjet Printing
- Direct Write
- Zip Dose
- Thermal Inkjet Printing
- Fused Deposition Modeling
- Powder Bed Printing
- Stereolithography (SLA)
- Semi Solid Extrusion (SSE)
3D Printed DrugsMarket– By Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
Asia Pacific
- China
- India
- South Korea
- Japan
- Australia
- Rest of Asia Pacific
Middle East and Africa
- South Africa
- Saudi Arabia
- UAE
- Rest of Middle East and Africa
South America
- Brazil
- Argentina
- Rest of South America
Company Profiles
- APRECIA PHARMACEUTICALS, LLC
- FabRx LTD
- Cycle Pharmaceuticals
- GLAXOSMITHKLINE PLC.
- ASTRAZENECA
- Tvasta
- Merck KGGA
- Terumo Corporation
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Dosage Forms ; Technology , and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
Frequently Asked Questions
3D Printed Drugs are medications, which are designed by 3D printing technique to customize for the individuals in a safer and effective way. These drugs have unitary porous structures that readily disperse in the mouth, because of which these high-dose medicines need not to be swallowed intact.
Increasing awareness of benefits offered by 3D printed drugs and growing emphasis on personalized medicines
Aprecia Pharmaceuticals, LLC and FabRx LTD are the major players in the market.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global 3D Printed Drugs Market – By Dosage Forms
1.3.2 Global 3D Printed Drugs Market – By Technology
1.3.3 Global 3D Printed Drugs Market – By Geography
2. 3D Printed Drugs Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global 3D Printed Drugs Market – Market Landscape
4.1 Overview
4.2 Pest Analysis
4.2.1 North America– PEST Analysis
4.2.2 Europe– PEST Analysis
4.2.3 Asia Pacific– PEST Analysis
4.2.4 Middle East & Africa– PEST Analysis
4.2.5 South and Central America – PEST Analysis
5. Global 3D Printed Drugs market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Adoption of Personalized Drugs
5.1.2 Increasing Prevalence of Dysphagia
5.2 Market Restraints
5.2.1 Usage of 3D Printing to Develop Illegal Drugs
5.3 Market Opportunities
5.3.1 Rising Awareness About the 3D Printing Technology
5.4 Future Trends
5.4.1 Adoption of Novel Technologies in 3D Drugs Printing to Streamline Procedural Outcomes
5.5 Impact analysis
6. 3D Printed Drugs Market– Global Analysis
6.1 Global 3D Printed Drugs Market Revenue Forecast And Analysis
6.2 Global 3D Printed Drugs Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. 3D Printed Drugs Market Analysis – By Dosage Forms
7.1 Overview
7.2 3D Printed Drugs Market Share, by Dosage Forms, 2019 and 2035, (%)
7.3 Tablets
7.3.1 Overview
7.3.2 Tablets: 3D Printed Drugs Market – Revenue and Forecast to 2027 (US$ Thousands)
7.3.3 Tablets: 3D Printed Drugs Market – Revenue and Forecast to 2035 (US$ Thousands)
7.4 Capsules
7.4.1 Overview
7.4.2 Capsules: 3D Printed Drugs Market – Revenue and Forecast to 2035 (US$ Thousands)
7.5 Multi Drug Implant
7.5.1 Overview
7.5.2 Multi Drug Implant: 3D Printed Drugs Market – Revenue and Forecast to 2035 (US$ Thousands)
7.6 Nanoparticles
7.6.1 Overview
7.6.2 Nanoparticles: 3D Printed Drugs Market – Revenue and Forecast to 2035 (US$ Thousands)
7.7 Solutions
7.7.1 Overview
7.7.2 Solutions: 3D Printed Drugs Market – Revenue and Forecast to 2035 (US$ Thousands)
7.8 Other Dosage Forms
7.8.1 Overview
7.8.2 Other Dosage Forms: 3D Printed Drugs Market – Revenue and Forecast to 2035 (US$ Thousands)
8. 3D Printed Drugs Market Analysis – By Technology
8.1 Overview
8.2 3D Printed Drugs Market Share, by Technology, 2019 and 2035 (%)
8.3 Inkjet Printing
8.3.1 Overview
8.3.2 Inkjet Printing: 3D Printed Drugs Market– Revenue and Forecast to 2035 (US$ Thousands)
8.4 Direct Write
8.4.1 Overview
8.4.2 Direct Write: 3D Printed Drugs Market– Revenue and Forecast to 2035 (US$ Thousands)
8.5 Zip Dose
8.5.1 Overview
8.5.2 Zip Dose: 3D Printed Drugs Market– Revenue and Forecast to 2027 (US$ Thousands)
8.5.3 Zip Dose: 3D Printed Drugs Market– Revenue and Forecast to 2035 (US$ Thousands)
8.6 Thermal Inkjet Printing
8.6.1 Overview
8.6.2 Thermal Inkjet: 3D Printed Drugs Market– Revenue and Forecast to 2035 (US$ Thousands)
8.7 Fused Deposition Modelling
8.7.1 Overview
8.7.2 Fused Deposition Modelling: 3D Printed Drugs Market – Revenue and Forecast to 2035 (US$ Thousands)
8.8 Powder Bed Printing
8.8.1 Overview
8.8.2 Powder Bed Printing: 3D Printed Drugs Market – Revenue and Forecast to 2035 (US$ Thousands)
8.9 Stereolithography (SLA)
8.9.1 Overview
8.9.2 Stereolithography (SLA): 3D Printed Drugs Market – Revenue and Forecast to 2035 (US$ Thousands)
8.10 Semi Solid Extrusion (SSE)
8.10.1 Overview
8.10.2 Semi Solid Extrusion (SSE): 3D Printed Drugs Market – Revenue and Forecast to 2035 (US$ Thousands)
9. 3D Printed Drugs Market – Geographic Analysis
9.1 North America: 3D Printed Drugs Market
9.1.1 Overview
9.1.2 North America: 3D Printed Drugs Market – Revenue and Forecast to 2027 (USD Thousands)
9.1.3 North America: 3D Printed Drugs Market – Revenue and Forecast to 2035 (USD Thousands)
9.1.4 North America: 3D Printed Drugs Market, by Dosage Forms, 2018–2027 (USD Thousands)
9.1.5 North America: 3D Printed Drugs Market, by Dosage Forms, 2028–2035 (USD Thousands)
9.1.6 North America: 3D Printed Drugs Market, by Technology, 2018–2027 (USD Thousands)
9.1.7 North America: 3D Printed Drugs Market, by Technology, 2028–2035 (USD Thousands)
9.1.8 North America: 3D Printed Drugs Market, by Country, 2028& 2035 (%)
9.1.9 US: 3D Printed Drugs Market – Revenue and Forecast (USD thousands)
9.1.9.1 US: 3D Printed Drugs Market – Revenue and Forecast to 2027 (USD Thousands)
9.1.9.2 US: 3D Printed Drugs Market – Revenue and Forecast to 2035 (USD Thousands)
9.1.9.3 US: 3D Printed Drugs Market, by Dosage Forms, 2018–2027 (USD Thousands)
9.1.9.4 US: 3D Printed Drugs Market, by Dosage Forms, 2028–2035 (USD Thousands)
9.1.9.5 US: 3D Printed Drugs Market, by Technology, 2018–2027 (USD Thousands)
9.1.9.6 US: 3D Printed Drugs Market, by Technology, 2028–2035 (USD Thousands)
9.1.10 Canada: 3D Printed Drugs Market – Revenue and Forecast (USD Thousands)
9.1.10.1 Canada: 3D Printed Drugs Market – Revenue and Forecast to 2035 (USD Thousands)
9.1.10.2 Canada: 3D Printed Drugs Market, by Dosage Forms, 2028–2035 (USD Thousands)
9.1.10.3 Canada: 3D Printed Drugs Market, by Technology, 2028–2035 (USD Thousands)
9.1.11 Mexico: 3D Printed Drugs Market – Revenue and Forecast (USD thousands)
9.1.11.1 Mexico: 3D Printed Drugs Market – Revenue and Forecast to 2035 (USD Thousands)
9.1.11.2 Mexico: 3D Printed Drugs Market, by Dosage Forms, 2028–2035 (USD Thousands)
9.1.11.3 Mexico: 3D Printed Drugs Market, by Technology, 2028–2035 (USD Thousands)
9.2 Europe: 3D Printed Drugs Market
9.2.1 Overview
9.2.2 Europe: 3D Printed Drugs Market – Revenue and Forecast to 2035 (USD Thousands)
9.2.3 Europe: 3D Printed Drugs Market, by Dosage Forms, 2028–2035 (USD Thousands)
9.2.4 Europe: 3D Printed Drugs Market, by Technology, 2028–2035 (USD Thousands)
9.2.5 Europe: 3D Printed Drugs Market, by Country, 2028 & 2035 (%)
9.2.6 Germany: 3D Printed Drugs Market
9.2.6.1 Germany: 3D Printed Drugs Market – Revenue and Forecast to 2035 (USD Thousands)
9.2.6.2 Germany: 3D Printed Drugs Market, by Dosage Forms, 2028–2035 (USD Thousands)
9.2.6.3 Germany: 3D Printed Drugs Market, by Technology, 2028–2035 (USD Thousands)
9.2.7 United Kingdom: 3D Printed Drugs Market
9.2.7.1 United Kingdom: 3D Printed Drugs Market – Revenue and Forecast to 2035 (USD Thousands)
9.2.7.2 United Kingdom: 3D Printed Drugs Market, by Dosage Forms, 2028–2035 (USD Thousands)
9.2.7.3 United Kingdom: 3D Printed Drugs Market, by Technology, 2028–2035 (USD Thousands)
9.2.8 France: 3D Printed Drugs Market
9.2.8.1 France: 3D Printed Drugs Market – Revenue and Forecast to 2035 (USD Thousands)
9.2.8.2 France: 3D Printed Drugs Market, by Dosage Forms, 2028–2035 (USD Thousands)
9.2.8.3 France: 3D Printed Drugs Market, by Technology, 2028–2035 (USD Thousands)
9.2.9 Italy: 3D Printed Drugs Market
9.2.9.1 Italy: 3D Printed Drugs Market – Revenue and Forecast to 2035 (USD Thousands)
9.2.9.2 Italy: 3D Printed Drugs Market, by Dosage Forms, 2028–2035 (USD Thousands)
9.2.9.3 Italy: 3D Printed Drugs Market, by Technology, 2028–2035 (USD Thousands)
9.2.10 Spain: 3D Printed Drugs Market
9.2.10.1 Spain: 3D Printed Drugs Market – Revenue and Forecast to 2035 (USD Thousands)
9.2.10.2 Spain: 3D Printed Drugs Market, by Dosage Forms, 2028–2035 (USD Thousands)
9.2.10.3 Spain: 3D Printed Drugs Market, by Technology, 2028–2035 (USD Thousands)
9.3 Asia Pacific: 3D Printed Drugs Market
9.3.1 Overview
9.3.2 Asia Pacific: 3D Printed Drugs Market – Revenue and Forecast to 2035 (USD Thousands)
9.3.3 Asia Pacific: 3D Printed Drugs Market, by Dosage Forms, 2028–2035 (USD Thousands)
9.3.4 Asia Pacific: 3D Printed Drugs Market, by Technology, 2028–2035 (USD Thousands)
9.3.5 Asia Pacific: 3D Printed Drugs Market, by Country, 2028 & 2035 (%)
9.3.6 China: 3D Printed Drugs Market
9.3.6.1 China: 3D Printed Drugs Market – Revenue and Forecast to 2035 (USD Thousands)
9.3.6.2 China: 3D Printed Drugs Market, by Dosage Forms, 2028–2035 (USD Thousands)
9.3.6.3 China: 3D Printed Drugs Market, by Technology, 2028–2035 (USD Thousands)
9.3.7 Japan: 3D Printed Drugs Market
9.3.7.1 Japan: 3D Printed Drugs Market – Revenue and Forecast to 2035 (USD Thousands)
9.3.7.2 Japan: 3D Printed Drugs Market, by Dosage Forms, 2028–2035 (USD Thousands)
9.3.7.3 Japan: 3D Printed Drugs Market, by Technology, 2028–2035 (USD Thousands)
9.3.8 India: 3D Printed Drugs Market
9.3.8.1 India: 3D Printed Drugs Market – Revenue and Forecast to 2035 (USD Thousands)
9.3.8.2 India: 3D Printed Drugs Market, by Dosage Forms, 2028–2035 (USD Thousands)
9.3.8.3 India: 3D Printed Drugs Market, by Technology, 2028–2035 (USD Thousands)
9.3.9 South Korea: 3D Printed Drugs Market
9.3.9.1 South Korea: 3D Printed Drugs Market – Revenue and Forecast to 2035 (USD Thousands)
9.3.9.2 South Korea: 3D Printed Drugs Market, by Dosage Forms, 2028–2035 (USD Thousands)
9.3.9.3 South Korea: 3D Printed Drugs Market, by Technology, 2028–2035 (USD Thousands)
9.3.10 Australia: 3D Printed Drugs Market
9.3.10.1 Australia: 3D Printed Drugs Market – Revenue and Forecast to 2035 (USD Thousands)
9.3.10.2 Australia: 3D Printed Drugs Market, by Dosage Forms, 2028–2035 (USD Thousands)
9.3.10.3 Australia: 3D Printed Drugs Market, by Technology, 2028–2035 (USD Thousands)
9.4 Middle East & Africa: 3D Printed Drugs Market
9.4.1 Overview
9.4.2 Middle East & Africa: 3D Printed Drugs Market – Revenue and Forecast to 2035 (USD Thousands)
9.4.3 Middle East & Africa: 3D Printed Drugs Market, by Dosage Forms, 2028–2035 (USD Thousands)
9.4.4 Middle East & Africa: 3D Printed Drugs Market, by Country, 2028 & 2035 (%)
9.4.5 Saudi Arabia: 3D Printed Drugs Market
9.4.5.1 Saudi Arabia: 3D Printed Drugs Market – Revenue and Forecast to 2035 (USD Thousands)
9.4.5.2 Saudi Arabia: 3D Printed Drugs Market, by Dosage Forms, 2028–2035 (USD Thousands)
9.4.5.3 Saudi Arabia: 3D Printed Drugs Market, by Technology, 2028–2035 (USD Thousands)
9.4.6 South Africa: 3D Printed Drugs Market
9.4.6.1 South Africa: 3D Printed Drugs Market – Revenue and Forecast to 2035 (USD Thousands)
9.4.6.2 South Africa: 3D Printed Drugs Market, by Dosage Forms, 2028–2035 (USD Thousands)
9.4.6.3 South Africa: 3D Printed Drugs Market, by Technology, 2028–2035 (USD Thousands)
9.4.7 UAE: 3D Printed Drugs Market
9.4.7.1 UAE: 3D Printed Drugs Market – Revenue and Forecast to 2035 (USD Thousands)
9.4.7.2 UAE: 3D Printed Drugs Market, by Dosage Forms, 2028–2035 (USD Thousands)
9.4.7.3 UAE: 3D Printed Drugs Market, by Technology, 2028–2035 (USD Thousands)
9.5 South and Central America: 3D Printed Drugs Market
9.5.1 Overview
9.5.2 South and Central America: 3D Printed Drugs Market – Revenue and Forecast to 2035 (USD Thousands)
9.5.3 South and Central America: 3D Printed Drugs Market, by Dosage Forms, 2028–2035 (USD Thousands)
9.5.4 South and Central America: 3D Printed Drugs Market, by Technology, 2028–2035 (USD Thousands)
9.5.5 South and Central America: 3D Printed Drugs Market, by Country, 2028 & 2035 (%)
9.5.6 Brazil: 3D Printed Drugs Market
9.5.6.1 Brazil: 3D Printed Drugs Market – Revenue and Forecast to 2035 (USD Thousands)
9.5.6.2 Brazil: 3D Printed Drugs Market, by Dosage Forms, 2028–2035 (USD Thousands)
9.5.6.3 Brazil: 3D Printed Drugs Market, by Technology, 2028–2035 (USD Thousands)
9.5.7 Argentina: 3D Printed Drugs Market
9.5.7.1 Argentina: 3D Printed Drugs Market – Revenue and Forecast to 2035 (USD Thousands)
9.5.7.2 Argentina: 3D Printed Drugs Market, by Dosage Forms, 2028–2035 (USD Thousands)
9.5.7.3 Argentina: 3D Printed Drugs Market, by Technology, 2028–2035 (USD Thousands)
10. Impact Of COVID-19 Pandemic On Global Rare Neurological Diseases Treatment Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact assessment of COVID-19 Pandemic
10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Rest of the World: Impact Assessment of COVID-19 Pandemic
11. 3D Printed Drugs Market –Industry Landscape
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 GlaxoSmithKline plc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Aprecia Pharmaceuticals, LLC.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 AstraZeneca
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 Key Developments
12.4 FabRx Ltd
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Merck KGaA
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Cycle Pharmaceuticals
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Tvasta
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 MSD
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. North America 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2027 (USD Thousands)
Table 2. North America 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2035 (USD Thousands)
Table 3. North America 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2027 (USD Thousands)
Table 4. North America 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2035 (USD Thousands)
Table 5. US 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2027 (USD Thousands)
Table 6. US 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2035 (USD Thousands)
Table 7. US 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2027 (USD Thousands)
Table 8. US 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2035 (USD Thousands)
Table 9. Canada 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2035 (USD Thousands)
Table 10. Canada 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2035 (USD Thousands)
Table 11. Mexico 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2035 (USD Thousands)
Table 12. Mexico 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2035 (USD Thousands)
Table 13. Europe 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2035(USD Thousands)
Table 14. Europe 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2035 (USD Thousands)
Table 15. Germany 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2035(USD Thousands)
Table 16. Germany 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2035 (USD Thousands)
Table 17. United Kingdom 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2035(USD Thousands)
Table 18. United Kingdom 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2035 (USD Thousands)
Table 19. France 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2035(USD Thousands)
Table 20. France 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2035 (USD Thousands)
Table 21. Italy 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2035(USD Thousands)
Table 22. Italy 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2035 (USD Thousands)
Table 23. Spain 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2035(USD Thousands)
Table 24. Spain 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2035 (USD Thousands)
Table 25. Asia Pacific 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2035(USD Thousands)
Table 26. Asia Pacific 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2035 (USD Thousands)
Table 27. China 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2035(USD Thousands)
Table 28. China 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2035 (USD Thousands)
Table 29. Japan 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2035(USD Thousands)
Table 30. Japan 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2035 (USD Thousands)
Table 31. India 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2035(USD Thousands)
Table 32. India 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2035 (USD Thousands)
Table 33. South Korea 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2035(USD Thousands)
Table 34. South Korea 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2035 (USD Thousands)
Table 35. Australia 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2035(USD Thousands)
Table 36. Australia 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2035 (USD Thousands)
Table 37. Middle East & Africa 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2035 (USD Thousands)
Table 38. Middle East & Africa 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2035 (USD Thousands)
Table 39. Saudi Arabia 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2035(USD Thousands)
Table 40. Saudi Arabia 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2035 (USD Thousands)
Table 41. South Africa 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2035(USD Thousands)
Table 42. South Africa 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2035 (USD Thousands)
Table 43. UAE 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2035(USD Thousands)
Table 44. UAE 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2035 (USD Thousands)
Table 45. South and Central America 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2035 (USD Thousands)
Table 46. South and Central America 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2035 (USD Thousands)
Table 47. Brazil 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2035(USD Thousands)
Table 48. Brazil 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2035 (USD Thousands)
Table 49. Argentina 3D Printed Drugs Market, by Dosage Forms – Revenue and Forecast to 2035(USD Thousands)
Table 50. Argentina 3D Printed Drugs Market, by Technology – Revenue and Forecast to 2035 (USD Thousands)
Table 1. Organic Developments Done By Companies
Table 2. Inorganic Developments Done By Companies
Table 3. Glossary of Terms, 3D Printed Drugs market
LIST OF FIGURES
Figure 1. 3D Printed Drugs Market Segmentation
Figure 2. 3D Printed Drugs Segmentation, By Region
Figure 3. Global 3D Printed Drugs Market Overview
Figure 4. The Tablets Segment Held Largest Share Of Dosage Forms Segment In 3D Printed Drugs Market (US$ Thousands)
Figure 5. North America Is Expected to Show Remarkable Growth During the Forecast Period (US$ Thousands)
Figure 6. Global 3D Printed Drugs Market, By Geography (US$ Thousands)
Figure 7. Global 3D Printed Drugs Market, Industry Landscape
Figure 8. North America PEST Analysis
Figure 9. Europe PEST Analysis
Figure 10. Asia Pacific PEST Analysis
Figure 11. Middle East & Africa PEST Analysis
Figure 12. South & Central America PEST Analysis
Figure 13. 3D printed drugs market impact analysis of driver and restraints
Figure 14. Global 3D Printed Drugs Market– Revenue Forecast And Analysis – 2019- 2027 (US$ Mn)
Figure 15. Market Positioning Of Key Players In Global 3D Printed Drugs Market
Figure 16. 3D Printed Drugs Market Share, by Dosage Forms, 2019 and 2035 (%)
Figure 17. Tablets: 3D Printed Drugs Market – Revenue and Forecast to 2027 (US$ Thousands)
Figure 18. Tablets: 3D Printed Drugs Market – Revenue and Forecast to 2035 (US$ Thousands)
Figure 19. Capsules: 3D Printed Drugs Market – Revenue and Forecast to 2035 (US$ Thousands)
Figure 20. Multi Drug Implant: 3D Printed Drugs Market – Revenue and Forecast to 2035 (US$ Thousands)
Figure 21. Nanoparticles: 3D Printed Drugs Market – Revenue and Forecast to 2035 (US$ Thousands)
Figure 22. Solutions: 3D Printed Drugs Market – Revenue and Forecast to 2035 (US$ Thousands)
Figure 23. Other Dosage Forms: 3D Printed Drugs Market – Revenue and Forecast to 2035 (US$ Thousands)
Figure 24. 3D Printed Drugs Market Share, by Technology, 2019 and 2035 (%)
Figure 25. Inkjet Printing: 3D Printed Drugs Market– Revenue and Forecast to 2035 (US$ Thousands)
Figure 26. Direct Write: 3D Printed Drugs Market– Revenue and Forecast to 2035 (US$ Thousands)
Figure 27. Zip Dose: 3D Printed Drugs Market– Revenue and Forecast to 2027 (US$ Thousands)
Figure 28. Zip Dose: 3D Printed Drugs Market– Revenue and Forecast to 2035 (US$ Thousands)
Figure 29. Thermal Inkjet: 3D Printed Drugs Market – Revenue and Forecast to 2035 (US$ Thousands)
Figure 30. Fused Deposition Modelling:3D Printed Drugs Market – Revenue and Forecast to 2035 (US$ Thousands)
Figure 31. Powder Bed Printing: 3D Printed Drugs Market – Revenue and Forecast to 2035 (US$ Thousands)
Figure 32. Stereolithography: 3D Printed Drugs Market – Revenue and Forecast to 2035 (US$ Thousands)
Figure 33. Semi Solid Extrusion (SSE): 3D Printed Drugs Market – Revenue and Forecast to 2035 (US$ Thousands)
Figure 34. North America: 3D Printed Drugs Market, by Key Country – Revenue (2019) (USD Thousands)
Figure 35. North America: 3D Printed Drugs Market, by Key Country – Revenue (2035) (USD Thousands)
Figure 36. North America 3D Printed Drugs Market Revenue and Forecast to 2027 (USD Thousands)
Figure 37. North America 3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)
Figure 38. North America: 3D Printed Drugs Market, by Country, 2028& 2035 (%)
Figure 39. US3D Printed Drugs Market Revenue and Forecast to 2027 (USD Thousands)
Figure 40. US3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)
Figure 41. Canada3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)
Figure 42. Mexico3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)
Figure 43. Europe: 3D Printed Drugs Market, by Key Country – Revenue (2028) (USD Thousands)
Figure 44. Europe3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)
Figure 45. Europe: 3D Printed Drugs Market, by Country, 2028 & 2035 (%)
Figure 46. Germany 3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)
Figure 47. United Kingdom3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)
Figure 48. France3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)
Figure 49. Italy3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)
Figure 50. Spain3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)
Figure 51. Asia Pacific: 3D Printed Drugs Market, by Key Country – Revenue (2028) (USD Thousands)
Figure 52. Asia Pacific3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)
Figure 53. Asia Pacific: 3D Printed Drugs Market, by Country, 2028 & 2035 (%)
Figure 54. China 3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)
Figure 55. Japan3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)
Figure 56. India3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)
Figure 57. South Korea3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)
Figure 58. Australia3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)
Figure 59. Middle East & Africa: 3D Printed Drugs Market, by Key Country – Revenue (2028) (USD Thousands)
Figure 60. Middle East & Africa3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)
Figure 61. Middle East & Africa: 3D Printed Drugs Market, by Country, 2028 & 2035 (%)
Figure 62. Saudi Arabia 3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)
Figure 63. South Africa3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)
Figure 64. UAE3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)
Figure 65. South and Central America: 3D Printed Drugs Market, by Key Country – Revenue (2028) (USD Thousands)
Figure 66. South and Central America3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)
Figure 67. South and Central America: 3D Printed Drugs Market, by Country, 2028 & 2035 (%)
Figure 68. Brazil 3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)
Figure 69. Argentina3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)
Figure 70. Impact of COVID-19 Pandemic In North American Country Markets
Figure 71. Impact of COVID-19 Pandemic In European Country Markets
Figure 72. Impact of COVID-19 Pandemic In Asia Pacific Country Markets
Figure 73. Impact Of COVID-19 Pandemic In North American Country Market
Figure 74. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - 3D Printed Drugs Market
- APRECIA PHARMACEUTICALS, LLC
- FabRx LTD
- Cycle Pharmaceuticals
- GLAXOSMITHKLINE PLC.
- ASTRAZENECA
- Tvasta
- Merck KGGA
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to 3D Printed Drugs Market
Apr 2020
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2020
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Apr 2020
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2020
Coagulation Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease Indications (Vitamin K Deficiency, Liver Disease, Disseminated Intravascular Coagulation & Pulmonary Embolism, Development of Circulating Anticoagulants, Hemophilia, Von Willebrand's Disease, and Others), Type [Clinical Laboratory Analyzers (Controls & Calibrators, Assays & Reagents, Instruments/Systems, Coagulation Factors, and Others) and Point-of-Care Testing Analyzers], Offering [Diagnosis (Prothrombin Time Testing, Fibrinogen Testing, Activated Clotting Time Testing, Activated Partial Thromboplastin Time Testing, D-Dimmer Testing, Platelets Function Testing, and Others) and Treatment (Anti-Fibrinolytic Drugs, Birth Control Pills, Desmopressin & Immunosuppressive Medicines, Vitamin K Supplements, Blood Thinners, Thrombin Inhibitors or Thrombolytics, Replacement Therapy, Catheter-Assisted Thrombus Removal, and Others)], Technology (Optical Technology, Mechanical Technology, Electrochemical Technology, and Others), End User (Clinical Laboratories, Hospitals, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2020
Pharmacy Automation Systems Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Automation Medication Dispensing Systems (Product Type and Operation), Automated Packaging and Labelling Systems, Automated Table-Top Counters, Automated Storage and Retrieval Systems, and Other Types], End User (Hospital Pharmacy, Retail Pharmacy, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2020
DNA Extraction, Isolation, and Purification Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type (Kits, Instruments, and Reagents), Method (Chemical Method and Physical Method), Sample Type (Blood, Body Fluids, and Others), Source (Genomic DNA and Microbial DNA), Application [PCR Test, Next Generation Sequencing (NGS), Microarray, and Others], End User (Hospitals, Diagnostic Centers and Research Laboratories, Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East and Africa and South and Central America)
Apr 2020
Molecular Diagnostic for Infectious Diseases Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type (Point-of-Care Testing and Laboratory Testing), End User [Point-of-Care Testing (Human Testing and Vet Testing) and Laboratory Testing (Human Testing and Vet Testing)], Application [Point-of-Care Testing (Detection of Single Pathogen, Detection of Two or More Pathogens, Evaluation of Emerging Novel Infections, Surveillance and Early Detection of Biothreat Agents and Diseases-Related Biomarker, and Antimicrobial Resistance Profiling) and Laboratory Testing (Patient stratification, Drug Regimen Selection, Toxicity Avoidance, Therapeutic Monitoring, and Detection of Predisposition to Disease)], Disease Type [Point-of-Care Testing (Sepsis, Prosthetic Joint Infection, Endocarditis, STDs, Mononucleosis, Group A Streptococcus, and Others) and Laboratory Testing (Sepsis, Prosthetic Joint infection, Endocarditis, STDs, Chlamydia, Gastrointestinal Infection, Tuberculosis, H1N1 Virus, and Others)], Infection Type [Point-of-Care Testing (Bacteria, Viral, Fungi, and Others) and Laboratory Testing (Bacteria, Viral, Fungi, and Others)], and Geography (North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa)
Apr 2020
Bovine Diagnostics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Immunoassay Kits, PCR Reagents & Kits, Hemagglutination Inhibition (HI) Assay, and Other Products), Disease Type [Bovine Viral Diarrhea (BVD), Bovine Tuberculosis (TB), Bovine Mastitis, Foot and Mouth Disease (FMD), and Other Disease Types], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography